Roche CEO Schwan throws cold water on talk of BioMarin takeover
This article was originally published in Scrip
Executive Summary
Roche CEO Severin Schwan disputed a key portion of a report detailing the Swiss company’s interest in buying US biotech company BioMarin Pharmaceutical.